These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 18487864)

  • 1. [Basic concepts in pharmacology: important terms in pharmacodynamics and pharmacokinetics].
    Singer E
    Onkologie; 2008; 31 Suppl 2():21-4. PubMed ID: 18487864
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics/pharmacodynamics in drug development: an industrial perspective.
    Chaikin P; Rhodes GR; Bruno R; Rohatagi S; Natarajan C
    J Clin Pharmacol; 2000 Dec; 40(12 Pt 2):1428-38. PubMed ID: 11185663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Introduction of quantitative methods in pharmacology and clinical pharmacology: a historical overview.
    Atkinson AJ; Lalonde RL
    Clin Pharmacol Ther; 2007 Jul; 82(1):3-6. PubMed ID: 17571065
    [No Abstract]   [Full Text] [Related]  

  • 4. [Biostatistical issues].
    Hudec M
    Onkologie; 2008; 31 Suppl 2():14-20. PubMed ID: 18487863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetic and pharmacodynamic modeling in vivo.
    Holford NH; Sheiner LB
    Crit Rev Bioeng; 1981; 5(4):273-322. PubMed ID: 7023829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. "Getting the dose right": facts, a blueprint, and encouragements.
    Peck CC; Cross JT
    Clin Pharmacol Ther; 2007 Jul; 82(1):12-4. PubMed ID: 17571068
    [No Abstract]   [Full Text] [Related]  

  • 7. Considerations on pharmacodynamics and pharmacokinetics: can everything be explained by the extent of drug binding to its receptor?
    Castañeda-Hernández G; Granados-Soto V
    Can J Physiol Pharmacol; 2000 Mar; 78(3):199-207. PubMed ID: 10721811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Maxsim2 - Real-time interactive simulations for computer-assisted teaching of pharmacokinetics and pharmacodynamics.
    Gabrielsson J; Andersson K; Tobin G; Ingvast-Larsson C; Jirstrand M
    Comput Methods Programs Biomed; 2014 Mar; 113(3):815-29. PubMed ID: 24461798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Using disease progression models as a tool to detect drug effect.
    Mould DR; Denman NG; Duffull S
    Clin Pharmacol Ther; 2007 Jul; 82(1):81-6. PubMed ID: 17507925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tailor-made drug treatment for children: creation of an infrastructure for data-sharing and population PK-PD modeling.
    Ince I; de Wildt SN; Tibboel D; Danhof M; Knibbe CA
    Drug Discov Today; 2009 Mar; 14(5-6):316-20. PubMed ID: 19059496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simulated drug administration: an emerging tool for teaching clinical pharmacology during anesthesiology training.
    Struys MM; De Smet T; Mortier EP
    Clin Pharmacol Ther; 2008 Jul; 84(1):170-4. PubMed ID: 18431407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative pharmacology or pharmacokinetic pharmacodynamic integration should be a vital component in integrative pharmacology.
    Gabrielsson J; Green AR
    J Pharmacol Exp Ther; 2009 Dec; 331(3):767-74. PubMed ID: 19779129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neonatal pharmacodynamics--basic principles. I: Drug delivery.
    Ohning BL
    Neonatal Netw; 1995 Mar; 14(2):7-12. PubMed ID: 7746242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Data documentation and data management with guidelines, experiences, caveats, and recommendations].
    Edler L; Pilz LR
    Onkologie; 2008; 31 Suppl 2():7-13. PubMed ID: 18487862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacotherapy in shock syndromes: the neglected field of pharmacokinetics and pharmacodynamics.
    Neugebauer E; Dietrich A; Lechleuthner A; Bouillon B; Eypasch E
    Circ Shock; 1992 Apr; 36(4):312-20. PubMed ID: 1623575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Limitations and pitfalls of clinical studies in oncology].
    Cerny T
    Onkologie; 2008; 31 Suppl 2():67-71. PubMed ID: 18487873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trial treatment length optimization with an emphasis on disease progression studies.
    Hennig S; Nyberg J; Hooker AC; Karlsson MO
    J Clin Pharmacol; 2009 Mar; 49(3):323-35. PubMed ID: 19246730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Commentary on Dartois et al.--model building in population PK-PD analyses. A 2002-2004 literature survey.
    Pillai G; Steimer JL
    Br J Clin Pharmacol; 2007 Nov; 64(5):578-9. PubMed ID: 17764478
    [No Abstract]   [Full Text] [Related]  

  • 19. [Pharmaceutical aspects of clinical trials: concepts of pharmacokinetic investigations].
    Czejka M
    Onkologie; 2008; 31 Suppl 2():29-33. PubMed ID: 18487866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Principles of pharmacology.
    Feucht C; Patel DR
    Pediatr Clin North Am; 2011 Feb; 58(1):11-9, ix. PubMed ID: 21281845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.